Analyst Ratings for Allos Therapeutics (ALTH) [Neutrals]
ALTH Rating Summary
ALTH Price Target Summary
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$1.50 (-18.5%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/10/2012 | Brean Capital | Downgrade | Hold (N/A) |
N/A (N/A) |
1.81 | 1.84 | 1.66% | Details |
| 1/23/2012 | JPMorgan | Downgrade | Neutral (N/A) |
N/A (N/A) |
1.51 | 1.84 | 21.85% | Details |
| 7/21/2011 | JMP Securities | Downgrade | Market Perform (N/A) |
N/A (N/A) |
2.06 | 1.84 | -10.68% | Details |
| 5/11/2011 | Needham & Company | Downgrade | Hold (N/A) |
N/A (N/A) |
2.72 | 1.84 | -32.35% | Details |
| 7/29/2010 | RBC Capital | Downgrade | Sector Perform (N/A) |
N/A (N/A) |
4.83 | 1.84 | -61.9% | Details |
| 7/20/2010 | Leerink Swann | Downgrade | Market Perform (N/A) |
N/A (N/A) |
5.87 | 1.84 | -68.65% | Details |
